Equities

OrbusNeich Medical Group Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

OrbusNeich Medical Group Holdings Ltd

Actions
  • Price (HKD)3.54
  • Today's Change-0.03 / -0.84%
  • Shares traded186.00k
  • 1 Year change+1.14%
  • Beta--
Data delayed at least 15 minutes, as of Mar 03 2026 03:57 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments249256248
Total Receivables, Net534635
Total Inventory564129
Prepaid expenses3.183.921.73
Other current assets, total0.460.430.45
Total current assets361348314
Property, plant & equipment, net281813
Goodwill, net10131.75
Intangibles, net9.769.564.06
Long term investments151613
Note receivable - long term------
Other long term assets1.772.121.76
Total assets431410351
LIABILITIES
Accounts payable6.844.824.07
Accrued expenses131214
Notes payable/short-term debt04.240
Current portion long-term debt/capital leases1.781.871.68
Other current liabilities, total8.87133.66
Total current liabilities313624
Total long term debt2.421.362.35
Total debt4.207.464.03
Deferred income tax0.870.97--
Minority interest1.071.02--
Other liabilities, total2.622.782.33
Total liabilities384228
SHAREHOLDERS EQUITY
Common stock0.410.410.41
Additional paid-in capital267278278
Retained earnings (accumulated deficit)14910862
Treasury stock - common(2.6)(0.82)--
Unrealized gain (loss)------
Other equity, total(21)(17)(17)
Total equity393368323
Total liabilities & shareholders' equity431410351
Total common shares outstanding828828828
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.